Neumega

In the US, Neumega (oprelvekin systemic) is a member of the following drug classes: interleukins, platelet-stimulating agents and is used to treat Thrombocytopenia Drug Induced.

US matches:

• Neumega


• Neumega injectable

Ingredient matches for Neumega

Oprelevkin

Oprelevkin is reported as an ingredient of Neumega in the following countries:

• Brazil


• Chile


• Colombia


• United States


• Venezuela

International Drug Name Search